ClassID:

169324

G01N33/6872 - page 3 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Recent Application in this class:
#601
20170321222
2017-11-09

Yeast cells expressing TAR DNA-binding protein 43 and uses therefor

#602
20170315115
2017-11-02

Dynamic switching biosensor

#603
20170312338
2017-11-02

Use of recombinant lymphocyte activation gene-3 as a companion therapeutic for patients at risk for cardiovascular disease and other chronic inflammatory diseases

#604
20170307593
2017-10-26

Methods for treating central or peripheral nervous system damage

#605
20170307590
2017-10-26

INHIBITORS OF MALARIAL AND HUMAN GLUCOSE TRANSPORTERS AND METHODS FOR IDENTIFYING THE INHIBITORS

#606
20170299609
2017-10-19

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS WITH SK CHANNEL ACTIVATORS

#607
20170299602
2017-10-19

Biomimetic chemical sensors using nanoelectronic readout of olfactory receptors

#608
20170298114
2017-10-19

Loss of function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits

#609
20170296555
2017-10-19

Targeting NCchannel for organ protection following ischemic episode

#610
20170296524
2017-10-19

Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases

#611
20170292961
2017-10-12

SYSTEMS AND METHODS FOR ASSESSING INTER-CELL COMMUNICATION

#612
20170285043
2017-10-05

Methods of identifying modulators of sestrin-gator-2 interaction for modulating mTORC1 activity

#613
20170285009
2017-10-05

Methods for identifying a receptor for a ligand and uses thereof

#614
20170276678
2017-09-28

Cell-free assay device and methods of use

#615
20170269064
2017-09-21

Method and kit for assessment of sodium channel-related anti- or pro-arrhythmic potential of compounds

#616
20170268056
2017-09-21

Methods of selecting T cell receptors using affinity oligonucleotide conjugates

#617
20170267651
2017-09-21

TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch

#618
20170266271
2017-09-21

Peptides and combination of peptides for use in immunotherapy against cancers

#619
20170260530
2017-09-14

Aptamers for purifying and quantifying gelsolin and its variants

#620
20170258948
2017-09-14

PD-L1 binding polypeptides for imaging

#621
20170253910
2017-09-07

Methods for delivering an analyte to transmembrane pores

#622
20170253882
2017-09-07

Target of VGSC β3 protein for prevention, treatment and diagnostic detection of cancers

#623
20170246248
2017-08-31

Oligopeptidic compounds and uses thereof

#624
20170242034
2017-08-24

Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)

#625
20170242033
2017-08-24

Epithelial cell spheroids and methods of making and using the same

#626
20170242009
2017-08-24

CSN5 polypeptides and uses thereof for screening therapeutic agents

#627
20170234886
2017-08-17

Multiplex immunohistochemical assay using primary antibodies of the same host species

#628
20170233813
2017-08-17

Diagnostic method for distinguishing forms of esophageal eosinophilia

#629
20170226204
2017-08-10

CD7 nanobodies, encoding sequence and use thereof

#630
20170226202
2017-08-10

Method for screening for autophagy activator or inhibitor

#631
20170226201
2017-08-10

Methods of diagnosing and treating hyperproliferative disorders

#632
20170219607
2017-08-03

Method for identifying epitope on protein

#633
20170219606
2017-08-03

CELL LINES EXPRESSING NaV AND METHODS OF USING THEM

#634
20170219582
2017-08-03

Antibodies with high affinity for alpha-Klotho

#635
20170218452
2017-08-03

Mutations associated with cystic fibrosis

#636
20170199201
2017-07-13

Surrogates of post-translationally modified proteins and uses thereof

#637
20170199200
2017-07-13

BIOMARKERS OF OXIDATIVE STRESS

#638
20170199199
2017-07-13

Compositions and methods for regulating glucose metabolism

#639
20170196996
2017-07-13

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

#640
20170183390
2017-06-29

Modified integrin polypeptides, modified integrin polypeptide dimers, and uses thereof

#641
20170175160
2017-06-22

Electrophysiological assays using oocytes that express human ENaC and the use of phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes

#642
20170168048
2017-06-15

Plasmonic substrates for metal-enhanced fluorescence based sensing, imaging and assays for cells

#643
20170160287
2017-06-08

USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS

#644
20170153246
2017-06-01

RECEPTORS OF RSPO2 AND RSPO3

#645
20170153245
2017-06-01

Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof

#646
20170153225
2017-06-01

A METHOD OF SCREENING FOR A COMPOUND CAPABLE OF STIMULATING GLUCOSE TRANSPORT INTO BROWN AND/OR BRITE ADIPOCYTES OF A MAMMAL, A KIT FOR USE IN SUCH A METHOD

#647
20170147359
2017-05-25

System and method for execution of a secured environment initialization instruction

#648
20170146457
2017-05-25

Human biosensors for heme binding

#649
20170145104
2017-05-25

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

#650
20170136045
2017-05-18

Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort

#651
20170132014
2017-05-11

System and method for execution of a secured environment initialization instruction

#652
20170131292
2017-05-11

Antibodies against human sodium channel nav 1.9

#653
20170115993
2017-04-27

System and method for execution of a secured environment initialization instruction

#654
20170115309
2017-04-27

Methods for screening voltage-gated proteins

#655
20170115308
2017-04-27

ASSAY TO MEASURE EFFICACY OF CDK8/19 INHIBITORS

#656
20170115279
2017-04-27

Diagnostic methods for neural disorders

#657
20170107225
2017-04-20

Heteroaryl derivatives as CFTR modulators

#658
20170106042
2017-04-20

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#659
20170101645
2017-04-13

Compositions and methods for modulating dysferlin expression

#660
20170101459
2017-04-13

Cleavage and exchange of major histocompatibility complex ligands employing azobenzene-containing peptides

#661
20170100374
2017-04-13

POTENTIATOR-CORRECTOR COMBINATIONS USEFUL IN THE TREATMENT OF CYSTIC FIBROSIS

#662
20170097364
2017-04-06

Method for diagnosing fibromyalgia syndrome, and kit therefor

#663
20170097361
2017-04-06

METHOD AND DEVICE FOR STABILIZING OF PROTEINS

#664
20170096396
2017-04-06

Process for making modulators of cystic fibrosis transmembrane conductance regulator

#665
20170089928
2017-03-30

Method for detection of basic peptide and reagent for detection of basic peptide

#666
20170089921
2017-03-30

EXPRESSION OF VOLTAGE-GATED ION CHANNELS IN CILIATES

#667
20170088894
2017-03-30

Methods of predicting acute rejection outcomes

#668
20170067918
2017-03-09

COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX

#669
20170067910
2017-03-09

Detection of platelet-derived shed CD31

#670
20170067909
2017-03-09

ASSAY-READY RECOMBINANT CELLS TRANSIENTLY OVEREXPRESSING GENES ENCODING DRUG TRANSPORTER PROTEINS AND/OR DRUG METABOLIZING ENZYMES

#671
20170067897
2017-03-09

Method of treatment employing cardiac glycoside

#672
20170067873
2017-03-09

Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays

#673
20170059559
2017-03-02

Modulation of synaptic maintenance

#674
20170051021
2017-02-23

PEPTIDE AGONISTS OF TOLL-LIKE RECEPTOR 5 LIGAND AND METHOD OF USE

#675
20170045530
2017-02-16

Methods for measuring analyte transport across barriers using X-ray fluorescence

#676
20170044267
2017-02-16

Endoglin antibodies

#677
20170044234
2017-02-16

Polypeptides and uses thereof for reducing CD95-mediated cell motility

#678
20170038395
2017-02-09

CD8+ REGULATORY T-CELLS FOR USE IN THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

#679
20170038394
2017-02-09

METHOD FOR THE IDENTIFICATION OF CD4+ REGULATORY T-CELLS FOR USE IN THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

#680
20170037143
2017-02-09

Targeted therapy to restore radioactive iodine transport in thyroid cancer

#681
20170035887
2017-02-09

Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies

#682
20170030924
2017-02-02

Method for Detecting a Systemic Inflammation and Test System

#683
20170029507
2017-02-02

Antigen binding constructs to CD8

#684
20170016912
2017-01-19

Human biosensors for detecting voltage changes

#685
20170016911
2017-01-19

METHOD FOR QUANTIFYING BIOLOGICAL MATERIAL BASED ON MULTIPLE IMMUNOSTAINING

#686
20170016881
2017-01-19

Screening method, a kit, a method of treatment and a compound for use in a method of treatment

#687
20170010257
2017-01-12

Human biosensors for detecting ATP

#688
20170010255
2017-01-12

Methods for identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder

#689
20170008946
2017-01-12

Mimetic peptides which modulate L-type calcium channels

#690
20170006871
2017-01-12

Methods of identifying insect-TRPA1 modulators

#691
20170003279
2017-01-05

Methods for determining modulators of insect transient receptor potential V (TRPV) channel

#692
20170002418
2017-01-05

Cystic fibrosis transmembrane conductance regulator gene mutations

#693
20160376655
2016-12-29

TRPC6 involved in glomerulonephritis

#694
20160376338
2016-12-29

Heat-sensing protein switches and uses thereof

#695
20160369348
2016-12-22

METHODS FOR DIAGNOSING AND TREATING MYHRE SYNDROME

#696
20160367634
2016-12-22

Method for achieving desired glial growth factor 2 plasma levels

#697
20160355588
2016-12-08

Bispecific CD3 and CD19 Antigen Binding Constructs

#698
20160348173
2016-12-01

Human blood molecular biodosimeter panel for distinguishing radiation exposure from inflammation stress

#699
20160334409
2016-11-17

Microparticle fractionation

#700
20160334391
2016-11-17

Selection of Agents Modulating Gastrointestinal Pain

#701
20160333414
2016-11-17

IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY

#702
20160333103
2016-11-17

Baff selective binding compounds and related methods

#703
20160333100
2016-11-17

CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT

#704
20160333095
2016-11-17

Humanized or chimeric CD3 antibodies

#705
20160333073
2016-11-17

DRUG DELIVERY SYSTEM

#706
20160332997
2016-11-17

Modulators of ATP-binding cassette transporters

#707
20160331995
2016-11-17

SYSTEM FOR OPTICAL STIMULATION OF TARGET CELLS

#708
20160326534
2016-11-10

Modulation of synaptic maintenance

#709
20160320414
2016-11-03

Assay for Detection of Transient Intracellular CA2+

#710
20160318931
2016-11-03

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#711
20160313305
2016-10-27

Methods of identifying modulators of olfactory receptors

#712
20160312240
2016-10-27

MODIFIED PYR/PYL RECEPTORS ACTIVATED BY ORTHOGONAL LIGANDS

#713
20160311893
2016-10-27

Anti-Complement factor H antibodies

#714
20160311871
2016-10-27

Resistant mutant 90 kDa heat shock protein

#715
20160297859
2016-10-13

Neuregulin variants and methods of screening and using thereof

#716
20160296445
2016-10-13

Reduction in CPC taste aversion by reducing CPC activation of TRPA1, TPRV1, or both

#717
20160289326
2016-10-06

Therapeutic and diagnostic methods for manipulating phagocytosis through calreticulin and low density lipoprotein-related receptor

#718
20160284081
2016-09-29

Cell analysis system, cell analysis program and cell analysis method

#719
20160282327
2016-09-29

DIAGNOSTIC METHODS FOR NEURAL DISORDERS

#720
20160274126
2016-09-22

BIOMARKERS FOR THE DIAGNOSIS OF INTERSTITIAL CYSTITIS

#721
20160271219
2016-09-22

LYMPHANGIOGENESIS-PROMOTING AGENTS

#722
20160266144
2016-09-15

Cardiotoxicity screening methods

#723
20160266095
2016-09-15

Method for identifying modulators of notch signaling

#724
20160258929
2016-09-08

Cell line, system and method for optical-based screening of ion-channel modulators

#725
20160252525
2016-09-01

CMET protein SRM/MRM assay

#726
20160252524
2016-09-01

Light-activated cation channel and uses thereof

#727
20160252523
2016-09-01

Method for removing genomically unstable IPS cells and synthetic peptide used therefor

#728
20160245802
2016-08-25

Target detection with nanopore

#729
20160237136
2016-08-18

NOVEL CELL LINES EXPRESSING ENaC and METHODS USING THEM

#730
20160231326
2016-08-11

Method for studying transport of an agent across a bilayer membrane in bioanalytical sensor applications

#731
20160231322
2016-08-11

Immunohistochemical assay for detection of CD3 and CD16

#732
20160221952
2016-08-04

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

#733
20160215038
2016-07-28

Soluble CD33 for treating myelodysplastic syndromes (MDS)

#734
20160209425
2016-07-21

USE OF DECTIN-1 ACTIVATORS FOR TREATMENT OF LIVER DISORDERS

#735
20160209424
2016-07-21

Kit for diagnosis, prognosis, and monitoring the immune status, of patients with chronic inflammatory diseases

#736
20160202269
2016-07-14

Method of treating pain with an antibody against netrin-4, Unc5B or neogenin

#737
20160202268
2016-07-14

METHOD OF DIAGNOSING KIDNEY DAMAGE IN DIABETIC PATIENTS USING URINARY CD36 AS A BIOMARKER

#738
20160200807
2016-07-14

Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use

#739
20160194312
2016-07-07

Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch

#740
20160187357
2016-06-30

Compositions and methods for increasing bone mineralization

#741
20160187352
2016-06-30

Methods and kits for predicting the risk of having a cardiovascular disease or event

#742
20160185844
2016-06-30

Modulation of synaptic maintenance

#743
20160176970
2016-06-23

PEPTIDE OR PEPTIDE COMPLEX BINDING TO ALPHA2 INTEGRIN AND METHODS AND USES INVOLVING THE SAME

#744
20160176951
2016-06-23

Synthetic library of specific binding molecules

#745
20160169911
2016-06-16

Marker for statin treatment stratification in heart failure

#746
20160168247
2016-06-16

Humanized or chimeric CD3 antibodies

#747
20160161514
2016-06-09

Simultaneous Assay of Target and Target-Drug Binding

#748
20160152708
2016-06-02

METHOD OF INHIBITING BINDING OR ACTIVITY OF MIF BY ADMINISTERING A MIF ANTAGONIST

#749
20160152677
2016-06-02

SINGLE DOMAIN TDF-RELATED COMPOUNDS AND ANALOGS THEREOF

#750
20160151457
2016-06-02

Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof

#751
20160146839
2016-05-26

Electrified compositions for determining the risk of developing adolescent idiopathic scoliosis through the use of GI protein receptor

#752
20160146793
2016-05-26

Kits, compositions and methods for detecting a biological condition

#753
20160145342
2016-05-26

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

#754
20160139146
2016-05-19

GI PROTEIN PHOSPHORYLATION AS MARKER FOR SCOLIOSIS AND SCOLIOSIS PROGRESSION, METHODS OF INCREASING GIPCR SIGNALING IN SCOLIOTIC SUBJECTS

#755
20160138107
2016-05-19

Mutations associated with cystic fibrosis

#756
20160137703
2016-05-19

MSP nanopores and related methods

#757
20160136237
2016-05-19

NGAL AND URINARY TRACT INFECTION

#758
20160130342
2016-05-12

Methods of treating cancer with antibodies that bind P2X7 receptors

#759
20160116485
2016-04-28

Compositions, methods, and assays using proteo-liposome-transfected oocytes for analyzing the structure, function, and activity of membrane proteins

#760
20160116476
2016-04-28

METHOD FOR SELECTING DUODENAL FLUID SAMPLE FOR DETECTING PANCREATIC DISEASE MARKER AND METHOD FOR DETECTING PANCREATIC DISEASE MARKER

#761
20160115475
2016-04-28

Treatment of insulin resistance through inhibitors of transcription factor TSC22D4

#762
20160115248
2016-04-28

Single domain antibodies directed against STAT3

#763
20160115244
2016-04-28

Single domain antibodies directed against KRAS

#764
20160096036
2016-04-07

Implantable prosthetic device comprising a cell expressing a channelrhodopsin

#765
20160083470
2016-03-24

Ferroportin antibodies and methods of use

#766
20160074374
2016-03-17

CORRECTORS ACTING THROUGH MSD1 OF CFTR PROTEIN

#767
20160069902
2016-03-10

MEASURING CIRCULATING THERAPEUTIC ANTIBODY, ANTIGEN AND ANTIGEN/ANTIBODY COMPLEXES USING ELISA ASSAYS

#768
20160069901
2016-03-10

Methods for identifying modulators of ion channels

#769
20160069900
2016-03-10

Immunoassay for soluble PD-L1

#770
20160069899
2016-03-10

Electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes

#771
20160068600
2016-03-10

Isolation of therapeutic target specific VNAR domains to ICOSL

#772
20160067212
2016-03-10

USE OF INSULIN SIGNALING ANTAGONISTS, OPTIONALLY IN COMBINATION OF TRANSFECTION OF NON-BETA CELLS, FOR INDUCING INSULIN PRODUCTION

#773
20160061843
2016-03-03

BIOMARKER ASSAY

#774
20160061833
2016-03-03

Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays

#775
20160061818
2016-03-03

Islet1 (ISl1) and hearing loss

#776
20160060297
2016-03-03

COMPSTATIN AND ANALOGS THEREOF FOR EYE DISORDERS

#777
20160058850
2016-03-03

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES OF INFECTIOUS AND NON-INFECTIOUS ORIGIN

#778
20160056960
2016-02-25

System and method for execution of a secured environment initialization instruction

#779
20160054298
2016-02-25

High Throughput Screen

#780
20160052993
2016-02-25

ALBUMIN VARIANTS BINDING TO FCRN

#781
20160047822
2016-02-18

BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF

#782
20160047821
2016-02-18

Method for monitoring cancer and/or inflammatory reaction based on RelB phosphorylation

#783
20160046907
2016-02-18

IN VITRO SYSTEM FOR GENERATION OF ANTIGEN-SPECIFIC IMMUNE RESPONSES

#784
20160046730
2016-02-18

DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF

#785
20160041188
2016-02-11

Peptide with gold binding and EGFR receptor affinity and same attached to gold nanostructure

#786
20160039902
2016-02-11

Channelrhodopsin variants and uses thereof

#787
20160032005
2016-02-04

METHODS AND PHARMACEUTICALS COMPOSITIONS FOR TREATING BREAST CANCERS

#788
20160025746
2016-01-28

Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand

#789
20160024590
2016-01-28

FALZ for use as a target for therapies to treat cancer

#790
20160024218
2016-01-28

Method of predicting survival time in myocardial infarction patients by measuring BAFF levels

#791
20160024215
2016-01-28

LLT-1 antibodies with new functional properties

#792
20160024209
2016-01-28

Antigen binding constructs to CD8

#793
20160022665
2016-01-28

Pharmaceutical Compositions and Administrations Thereof

#794
20160015010
2016-01-21

Animal model of Charcot-Marie-Tooth disease as HSP27 mutant (S135F) carrier

#795
20160009811
2016-01-14

Endoglin antibodies

#796
20160009772
2016-01-14

CELL PENETRATING PEPTIDES WHICH BIND IRF5

#797
20160003847
2016-01-07

Detection and Treatment of Pancreatic, Ovarian and Other CD70 Positive Cancers

#798
20160003846
2016-01-07

Method for inhibiting the SWAP-70 protein

#799
20160003804
2016-01-07

Compositions and methods for modulating c-Rel-dependent cytokine production

#800
20160002322
2016-01-07

Antibodies against TM4SF5 and methods of use thereof

#801
20160000800
2016-01-07

MODULATORS AND METHODS FOR THE TREATMENT OF ROSACEA

#802
20150376705
2015-12-31

METHOD TO PREDICT THE PATTERN OF LOCOMOTION IN HORSES

#803
20150369821
2015-12-24

NOVEL LIPOCALIN-MUTEIN ASSAYS FOR MEASURING HEPCIDIN CONCENTRATION

#804
20150369820
2015-12-24

NOVEL DISEASE-MARKER

#805
20150369819
2015-12-24

TMEM120A ion channel modulator

#806
20150369740
2015-12-24

Optogenetic probes for measuring membrane potential

#807
20150368326
2015-12-24

Modulation of synaptic maintenance

#808
20150368325
2015-12-24

Modulation of synaptic maintenance

#809
20150368324
2015-12-24

Modulation of synaptic maintenance

#810
20150355184
2015-12-10

Antibodies that bind to human programmed death ligand 1 (PD-L1)

#811
20150355163
2015-12-10

T-TYPE CALCIUM CHANNEL INHIBITORS FOR TREATMENT OF CANCER

#812
20150353637
2015-12-10

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

#813
20150346217
2015-12-03

USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS

#814
20150346216
2015-12-03

DEVICES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF WOUNDS USING BIOMARKERS

#815
20150344958
2015-12-03

Method of screening compounds for the treatment of diabetes

#816
20150344526
2015-12-03

Biologically active complex and its preparation

#817
20150343063
2015-12-03

Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies

#818
20150336974
2015-11-26

Cyclic sulfonamides as sodium channel blockers

#819
20150330995
2015-11-19

MCAM as a biomarker for fluid homeostasis

#820
20150330971
2015-11-19

SYSTEMS AND METHODS FOR DETECTING A BIOLOGICAL CONDITION

#821
20150323553
2015-11-12

Methods for the prevention or treatment of scoliosis

#822
20150323549
2015-11-12

Methods for Identifying Compounds That Modulate Ion Channel Activity of a Kir Channel

#823
20150323548
2015-11-12

METHODS OF MONITORING THE MODULATION OF THE KINASE ACTIVITY OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USES OF SAID METHODS

#824
20150322132
2015-11-12

T1R taste receptors and genes encoding same

#825
20150316550
2015-11-05

Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside

#826
20150315286
2015-11-05

GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF

#827
20150315186
2015-11-05

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#828
20150315151
2015-11-05

PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

#829
20150309049
2015-10-29

Systems and methods for determining a chemical state

#830
20150307611
2015-10-29

Methods for diagnosing and treating inflammatory bowel disease

#831
20150301045
2015-10-22

NON-B-LINEAGE CELLS CAPABLE OF PRODUCING ANTIBODY

#832
20150301029
2015-10-22

Diagnostic methods for neural disorders

#833
20150301028
2015-10-22

ANALYSIS OF COMPOUNDS FOR PAIN AND SENSORY DISORDERS

#834
20150299708
2015-10-22

CD133 aptamers for detection of cancer stem cells

#835
20150299322
2015-10-22

Agents that modulate immune cell activation and methods of use thereof

#836
20150297676
2015-10-22

COMPOSITION COMPRISING GRIM-19 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING OBESITY OR LIPID-RELATED METABOLIC DISEASES

#837
20150293095
2015-10-15

Systems and methods for detecting a biological condition

#838
20150291963
2015-10-15

Sortilin 1 is a novel inducer of vascular calcification

#839
20150291662
2015-10-15

Modified peptide, CB receptor ligand, kit in vitro process for evaluating CB receptor bonds, uses, pharmaceutical composition for modulating CB receptor activity

#840
20150285820
2015-10-08

Optogenetic probes for measuring membrane potential

#841
20150276760
2015-10-01

Method for Screening a Compound Capable of Inhibiting the Notch1 Transcriptional Activity

#842
20150276723
2015-10-01

Salivary protein glycosylation test for diagnosis and monitoring of diabetes

#843
20150276603
2015-10-01

Method of analyzing image of cell in laminated structure and method of evaluating laminated structure for corneal transplantation

#844
20150274839
2015-10-01

Antibodies to non-functional P2X7 receptor

#845
20150273083
2015-10-01

Methods for the diagnosis and treatment of sjögren's syndrome

#846
20150272907
2015-10-01

Methods and compositions for modifying sensorial perception

#847
20150265612
2015-09-24

Heteroaryl derivatives as CFTR modulators

#848
20150260728
2015-09-17

Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation

#849
20150259429
2015-09-17

CLUSTER OF DIFFERENTIATION 36 (CD36) AS A THERAPEUTIC TARGET FOR HIV INFECTION

#850
20150259428
2015-09-17

CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same

#851
20150259412
2015-09-17

Method of treating sepsis by administering a soluble CD52 glycoprotein

#852
20150257998
2015-09-17

TRPV1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same

#853
20150253339
2015-09-10

NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM

#854
20150253305
2015-09-10

METHODS OF IDENTIFYING COMPOUNDS FOR TREATING DEPRESSION AND OTHER RELATED DISEASES

#855
20150253303
2015-09-10

LRRC8 proteins and protein complexes and methods for identification of channel modulators

#856
20150248949
2015-09-03

Hydrogel network

#857
20150246945
2015-09-03

Peptides that bind to epithelial cell adhesion molecule

#858
20150241449
2015-08-27

Molecularly imprinted polymer for detection of pentraxin protein and method for preparing the same

#859
20150241448
2015-08-27

LANTHIONINE SYNTHETASE COMPONENT C-LIKE PROTEINS AS MOLECULAR TARGETS FOR PREVENTING AND TREATING DISEASES AND DISORDERS

#860
20150239982
2015-08-27

Anti-presepsin antibody

#861
20150239964
2015-08-27

Use of regulatory T cell-specific surface protein LRIG-1

#862
20150233943
2015-08-20

BLID; protein domain for interaction with the Bcl-2 family of proteins

#863
20150226749
2015-08-13

Method for measuring the level of circulating inhibitory factor 1 protein in a subject measuring the level of circulating inhibitory factor 1 (IF1) protein in a subject

#864
20150224101
2015-08-13

Method and compositions for treating cancer and related methods

#865
20150210761
2015-07-30

Antibody specifically binding to ANG2 and use thereof

#866
20150198615
2015-07-16

Method for measuring analyte transport across cell membranes using X-ray fluorescence

#867
20150198614
2015-07-16

Beclin 1 phosphorylation

#868
20150198613
2015-07-16

Soluble MANF in pancreatic β-cell disorders

#869
20150197571
2015-07-16

Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use

#870
20150192593
2015-07-09

BIOMARKERS FOR DIAGNOSING AND/OR MONITORING TUBERCULOSIS

#871
20150185222
2015-07-02

Method for detecting cancer via measurement of caprin-1 expression level

#872
20150185202
2015-07-02

Simultaneous detection of cannibalism and senescence as prognostic marker for cancer

#873
20150184163
2015-07-02

Diagnostic and screening methods for atopic dermatitis

#874
20150183874
2015-07-02

Humanized and chimeric monoclonal antibodies to CD47

#875
20150182644
2015-07-02

Compounds and methods for the detection of TRPV-6 cancers and drug delivery

#876
20150174203
2015-06-25

Compositions And Methods For Modulating Pro-Inflammatory Immune Response

#877
20150168424
2015-06-18

IGFBP2 Biomarker

#878
20150168423
2015-06-18

Cardiovascular Risk Event Prediction and Uses Thereof

#879
20150166668
2015-06-18

Antibodies and conjugates that target misfolded prion protein

#880
20150165227
2015-06-18

Light-activated cation channel and uses thereof

#881
20150164883
2015-06-18

PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF

#882
20150160237
2015-06-11

Compositions of cardiomyocyte subpopulations

#883
20150158921
2015-06-11

αO-superfamily conotoxin peptide, pharmaceutical composition and use thereof

#884
20150152511
2015-06-04

Cereblon isoforms and their use as biomarkers for therapeutic treatment

#885
20150152090
2015-06-04

COMPOSITIONS AND METHODS FOR TREATMENT

#886
20150152077
2015-06-04

SecA inhibitors and methods of making and using thereof

#887
20150148245
2015-05-28

Methods of monitoring responsiveness to anti-SMAD7 therapy

#888
20150140127
2015-05-21

Method for detecting injury to the brain

#889
20150140081
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#890
20150140080
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#891
20150140079
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#892
20150140078
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#893
20150140077
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#894
20150140075
2015-05-21

COMPOSITIONS AND METHODS FOR TREATMENT

#895
20150132774
2015-05-14

Fluorescent protein voltage sensors for measuring membrane potential and imaging high-frequency neuronal electrical activity

#896
20150126448
2015-05-07

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#897
20150125881
2015-05-07

Methods of assessing the immunomodulatory potential of a multipotent stromal cell (MSC) population, and systems and kits for practicing the same

#898
20150125878
2015-05-07

Antibodies against CD106 (VCAM-1)

#899
20150119476
2015-04-30

DEVELOPMENT, CHARACTERIZATION, AND USE OF AN ANTI-HYPUSINATED eIF5A ANTIBODY TO DIAGNOSE DIABETES

#900
20150119441
2015-04-30

Modulators of ATP-Binding Cassette Transporters